Author:
Harrison Tim J.,Dusheiko Geoffrey M.
Reference57 articles.
1. Alper, C.A., Kruskall, M.S., Marcus-Bagley, D. et al. (1989) Genetic prediction of non-response to hepatitis B vaccine. New Engl. J. Med., 321, 708–12.
2. Alter, M. J., Coleman, P.J., Alexander, W.J. et al. (1989) Importance of heterosexual activity in the transmission of hepatitis B and non-A, non-B hepatitis. JAMA, 262, 1201–5.
3. Alter, H.J. (1982) The evolution, implications and applications of the hepatitis B vaccine. JAMA, 247, 2272–5.
4. Andre, F.E. (1988) Clinical experience with a recombinant DNA hepatitis B vaccine. South East Asian J. Trap. Med. Public Health, 19, 501–10.
5. Baddour, L.M., Bucak, V.A., Somes, G. and Hudson, R. (1988) Risk factors for hepatitis B virus infection in black female attendees of a sexually transmitted disease clinic. Sex. Transm. Dis., 15, 174–6..